Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-13-028319
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-23 12:13:12
Reporting Period:
2013-05-21
Filing Date:
2013-05-23
Accepted Time:
2013-05-23 12:13:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1226616 Medicinova Inc MNOV Pharmaceutical Preparations (2834) 330927979
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362520 Arlene Morris C/o Medicinova, Inc.
4275 Executive Square, Suite 650
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-21 1,000 $2.77 1,000 No 4 M Direct
Common Stock Acquisiton 2013-05-21 7,800 $2.40 8,800 No 4 M Direct
Common Stock Disposition 2013-05-21 8,800 $3.28 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-05-21 1,000 $0.00 1,000 $2.77
Common Stock Stock Option (Right to Buy) Disposition 2013-05-21 7,800 $0.00 44,000 $2.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-12-12 2019-06-11 No 4 M Direct
36,200 2021-07-17 No 4 M Direct
Footnotes
  1. 30,000 of the Shares underlying the Stock Option vested and became exercisable on January 18, 2011, and the remainder vested and became exercisable on January 18, 2012.